Covered recipient · General Payments record
ANTHONY GERMINARIO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$2,463.79
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $736.55 | 32 |
| Education | $94.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $185.02 | 10 |
| Gilead Sciences, Inc. | $155.07 | 2 |
| Lilly USA, LLC | $110.65 | 5 |
| Astellas Pharma US Inc | $94.99 | 1 |
| ABBVIE INC. | $86.87 | 5 |
| Novo Nordisk AS | $65.12 | 3 |
| Acerta Pharma LLC | $33.13 | 2 |
| Amgen Inc. | $32.37 | 1 |
| GlaxoSmithKline, LLC. | $22.37 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.01 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.69 | 1 |
| CeQur Corporation | $14.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.07 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789939 | CMS |
| ABBVIE INC. | $25.30 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789941 | CMS |
| ABBVIE INC. | $14.18 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789943 | CMS |
| ABBVIE INC. | $14.42 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789945 | CMS |
| ABBVIE INC. | $16.90 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789947 | CMS |
| Amgen Inc. | $32.37 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111582672 | CMS |
| Astellas Pharma US Inc | $94.99 | 03/13/2024 | Education | Undisputed | 01/23/2026 | 1139345730 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.01 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104722435 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.12 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104412827 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.69 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086237912 | CMS |
| CeQur Corporation | $14.25 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126847092 | CMS |
| Gilead Sciences, Inc. | $20.07 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133741042 | CMS |
| Gilead Sciences, Inc. | $135.00 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133741044 | CMS |
| GlaxoSmithKline, LLC. | $22.37 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116318518 | CMS |
| Lilly USA, LLC | $25.98 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051113 | CMS |
| Lilly USA, LLC | $24.77 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136059972 | CMS |
| Lilly USA, LLC | $21.80 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051115 | CMS |
| Lilly USA, LLC | $16.83 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051117 | CMS |
| Lilly USA, LLC | $21.27 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051119 | CMS |
| Novo Nordisk Inc | $21.72 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097080357 | CMS |
| Novo Nordisk Inc | $22.99 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096683846 | CMS |
| Novo Nordisk Inc | $20.41 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097659942 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.01 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118897296 | CMS |
| PFIZER INC. | $17.97 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130997452 | CMS |
| PFIZER INC. | $19.83 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131071855 | CMS |
| PFIZER INC. | $18.49 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131354317 | CMS |
| PFIZER INC. | $18.30 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131466935 | CMS |
| PFIZER INC. | $13.89 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131486319 | CMS |
| PFIZER INC. | $22.04 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131515549 | CMS |
| PFIZER INC. | $18.21 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131782856 | CMS |
| PFIZER INC. | $18.97 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131848286 | CMS |
| PFIZER INC. | $17.89 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131863435 | CMS |
| PFIZER INC. | $19.43 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132103941 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.